Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
Nancy Chan(Unknown), Linda T. Vahdat(Dartmouth–Hitchcock Medical Center), Eleni Nackos(Cornell University), Tessa Cigler(Cornell University), Amy D. Willis(Cornell University), Elnaz Aljom(NewYork–Presbyterian Hospital), Sarah Schneider(Cornell University), J. David Warren(Cornell University), Claudia Fischbach(Cornell University), Maureen E. Lane(Cornell University), Jessica Guillaume-Abraham(Cornell University), Naomi Kornhauser(Cornell University), Diana Donovan(Brigham and Women's Hospital), Vivek Mittal(Cornell University), Bo Ri Seo(Harvard University), Anne Moore(Cornell University), Veronica Fitzpatrick(Aurora Health Care), Maureen M. Ward(Cornell University), Marta Vallee Cobham(Cornell University), Alysia Wiener(Detroit Medical Center), Sharrell B. Lee(Cornell University), Ellen Chuang(SUNY Upstate Medical University), Richard Zelkowitz(Norwalk Hospital)
Cited by 224
Related Papers
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
|Nature|2015|1.8k
Connecting copper and cancer: from transition metal signalling to metalloplasia
|Nature reviews. Cancer|2021|1.3k
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
|The Lancet|2011|1.1k
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846